Guidelines for Chronic Opioid Therapy Refills

Core Principles for Opioid Refills

The American Medical Association recommends establishing clear treatment goals for both pain relief and functional improvement before initiating chronic opioid therapy, and discussing how therapy will be discontinued if benefits do not outweigh risks 1
The Centers for Disease Control and Prevention suggests prescribing the lowest effective dosage, using caution at any dose and carefully reassessing when considering doses ≥50 morphine milligram equivalents (MME) per day 3, 4
The American Medical Association advises avoiding increasing dosage to ≥90 MME/day or carefully justifying a decision to titrate to this level 4, 5
The Centers for Disease Control and Prevention recommends evaluating benefits and harms within 1-4 weeks of starting opioid therapy or dose escalation, then every 3 months or more frequently 2

The American Medical Association recommends reviewing the patient's history of controlled substance prescriptions using state prescription drug monitoring program (PDMP) data before each refill 1
The American Medical Association suggests conducting urine drug testing before initiating opioid therapy and periodically during treatment to monitor adherence 6
The Centers for Disease Control and Prevention advises documenting comprehensive reassessment of pain, function, and quality of life using validated tools such as the PEG scale (Pain, Enjoyment, General activity) 2
The Centers for Disease Control and Prevention recommends monitoring for signs of opioid use disorder, including difficulty controlling use and work/family problems related to opioid use 2
The American Medical Association suggests assessing for adverse effects including constipation, sedation, and respiratory depression 7

The American Medical Association recommends considering offering naloxone when risk factors for overdose are present (history of overdose, substance use disorder, doses ≥50 MME/day, or concurrent benzodiazepine use) 1
The American Medical Association advises avoiding concurrent prescribing of opioids and benzodiazepines whenever possible 8
The American Medical Association suggests storing opioids in a secure, preferably locked location and discussing options for safe disposal of unused medications 6

The American Medical Association recommends using particular caution with methadone due to its unique risk profile and complex pharmacokinetics; it should not be the first choice for an extended-release/long-acting opioid 3
The American Medical Association advises exercising special care with fentanyl, as its dosing effects are often misunderstood and its absorption can be affected by heat and other factors 1, 3

The American Medical Association recommends checking PDMP data before refills, which can miss doctor shopping or dangerous drug combinations 1
The Centers for Disease Control and Prevention advises against automatically refilling prescriptions without reassessing benefits and risks 2
The American Medical Association suggests ensuring adequate documentation of functional improvement, which is critical for justifying continued therapy 1